Form 4: HeartBeam Director George de Urioste Reports Changes in Beneficial Ownership

Director George de Urioste reports acquisition and disposal of HeartBeam, Inc. common stock and restricted stock units.

Summary

• On June 12, 2024, George de Urioste, a director of HeartBeam, Inc., reported changes in beneficial ownership of the company's securities.
• De Urioste acquired 33,185 shares of common stock at $0 and disposed of 69,314 shares.
• Following these transactions, de Urioste beneficially owns 69,314 shares of common stock.
• De Urioste also holds options to purchase 44,000 shares of common stock at an exercise price of $4.25, granted on November 12, 2021, vesting monthly from September 27, 2021.
• The reported transactions include restricted stock units (RSUs) that vest on the earlier of June 12, 2025, or the date of the Issuer's 2025 annual meeting of stockholders, contingent on continued service as an Outside Director.

Sentiment

Score: 5

Explanation: This is a routine disclosure of stock transactions by a company director. It doesn't inherently indicate positive or negative sentiment, but rather provides transparency.

Future Outlook

The vesting of RSUs is contingent on the Reporting Person continuing to be an Outside Director through the applicable vesting date.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to monitor potential shifts in ownership and sentiment.

Stakeholder Impact

• The reported transactions provide shareholders with insight into the director's holdings and recent trading activity.
• The vesting of RSUs incentivizes the director to remain with the company.

Key Dates